intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. The finding adds to mounting ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

did not prevent prostate cancer. Gaziano et al. reported the outcomes of the Physicians' Health Study II, which assessed the effects of vitamin C (500 µg per day synthetic ascorbic acid ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

Does it help prevent cancer? Maybe. Free radicals damage ... Researchers in China and Italy have started clinical trials with IV-administered vitamin C. But it's too early to tell with vitamin ...

High-dose intravenous vitamin C doubles survival in metastatic pancreatic cancer, extending life without added toxicity or ...

Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The ...

Science is difficult and not as easy to absorb as this,” says Dr Prashant Mehta, medical oncologist at Amrita Hospital, ...